ClinicalTrials.Veeva

Menu

The Impact of Physiologic Cataract Surgery on Patient Comfort and Medication Usage

M

Matthew Rauen

Status

Not yet enrolling

Conditions

Cataract Surgery Experience
Cataract Surgery Anesthesia
Nuclear Cataract
Cataract and IOL Surgery

Treatments

Device: Low IOP Setting
Device: High IOP Setting

Study type

Interventional

Funder types

Other

Identifiers

NCT07223866
IIT #98621123

Details and patient eligibility

About

The study will pertain to investigating the impact of high vs low IOP on the intraoperative experience and comfort for the patient and surgeon. Our hypothesis is that operating at a more physiological IOP using Unity VCS/CS and Centurion with Active Sentry at a higher, or more traditional IOP will result in significantly less discomfort/pain as assessed by the decreased need for rescue medication and lower VAS scores.

Full description

Objective/ Unmet Medical Need:

To investigate the impact of Unity VCS/CS with Intelligent Fluidics at a low IOP setting and Centurion with Active Sentry at a traditionally high IOP setting on the intraoperative experience for the patient and surgeon. Limited research on phacoemulsification at near physiological IOP and its impact on patient discomfort/pain using the Unity VCS/CS system.

Design:

Prospective, single-surgeon, eyes undergoing phacoemulsification will be randomized to high (IOP 65mmHg) or low (IOP 25mmHg) IOP, contralateral eye will receive other treatment.

STUDY HYPOTHESIS Unity VCS/CS with Intelligent Fluidics during cataract surgery will result in significantly less discomfort/pain as assessed by the decreased need for rescue medication and lower VAS scores.

Enrollment

85 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Subjects who will require bilateral cataract surgery will be considered. Evaluations will occur in the clinic of the Principal Investigator (PI) Matthew Rauen, MD at the Wolfe Eye Clinic.

Inclusion Criteria:

  • Visually significant cataract 2-3+ undergoing uncomplicated cataract surgery with similar cataract grade in both eyes
  • Unremarkable ocular health but inclusive of early AMD

Exclusion Criteria:

  • H/o ocular surgery including corneal refractive surgery
  • Compromised zonular integrity or stability
  • Uncontrolled diabetes and diabetic retinopathy
  • Small pupils
  • H/o systemic inflammatory disease/uveitis
  • H/o chronic pain medications (including narcotics) and benzodiazepine usage
  • Abnormal liver or renal function

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

85 participants in 2 patient groups

Centurion with Active Sentry at a traditionally high IOP setting
Active Comparator group
Description:
Centurion with Active Sentry at a traditionally high IOP setting, Eyes in this arm will maintain an Intraocular Pressure (IOP) of 65 millimeters of mercury (mmHg) throughout the cataract surgery.
Treatment:
Device: High IOP Setting
Unity VCS/CS with Intelligent Fluidics at a low IOP setting
Active Comparator group
Description:
Unity VCS/CS with Intelligent Fluidics at a low IOP setting. Eyes in this arm will maintain an Intraocular Pressure (IOP) of 25 millimeters of mercury (mmHg) throughout the cataract surgery.
Treatment:
Device: Low IOP Setting

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Robyn Kohler, RN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems